Anthrax: US FDA approves Emergent BioSolutions Vaccine
Emergent BioSolutions said on Thursday the U.S. Food and Drug Administration has approved its anthrax vaccine for use in adults aged 18 through 65.
The vaccine, Cyfendus, has been approved for use following suspected or confirmed exposure…